RDRich Milton R. Dulay

Rich Milton R. Dulay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rich Milton R. Dulay has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioactivity Research in Ganoderma lucidum: A Scientometric Analysis of Global Trends, Translational Gaps, and Emerging Research Frontiers

    by Christian Joseph N. Ong, Jamil Allen G. Fortaleza, Jowi Tsidkenu Pili Cruz, Edison D. Ramos, Joel G. Matamis, Janice Kaylyn Lonogan, Amelda C. Libres, Carina M. Magtibay, Jose Edwardo R. Mamaat, Maylaine M. de Leon, et al.

    Ganoderma lucidum (Lingzhi or Reishi) is among the most extensively studied medicinal mushrooms globally, owing to its diverse bioactive compounds and broad pharmacological properties. A scientometric analysis using the Scopus database was conducted to investigate global research trends on the bioactivity of G. lucidum. Bibliometric indicators, collaboration networks, keyword co-occurrence, thematic evolution, conceptual structure mapping, and life cycle modeling were assessed using Bibliometrix/Biblioshiny and VOSviewer version 1.6.20. A total of 2877 publications were included in the analysis. Scientific output increased markedly after 2010, peaking in 2025, indicating sustained growth in the field. China was identified as the leading contributor in terms of publication volume, influential authors, and prominent institutions, while international collaboration networks showed expanding global participation. Keyword and thematic analyses demonstrated a shift from early research focused on bioactivity screening, polysaccharides, and cultivation to mechanistic and translational investigations involving apoptosis, oxidative stress, immunomodulation, metabolomics, gut microbiota, network pharmacology, and disease-specific applications. Life cycle analysis suggested that the field is still in a rapid growth phase and has not yet reached saturation. Research on G. lucidum has evolved into a mature and highly interdisciplinary field, characterized by increasing scientific productivity, expanding international collaboration, and a growing emphasis on mechanistic and translational studies.

  • Open Access

    Artificial Intelligence in Bacteriophage Science: A Comprehensive Narrative Review of Applications, Challenges, and Translational Opportunities

    by Jamil Allen G. Fortaleza, Kevin Smith P. Cabuhat, Herminiño C. Lagunzad, Warren B. Panizales, Jowi Tsidkenu Pili Cruz, Joel G. Matamis, Jose Edwardo R. Mamaat, Amelda C. Libres, Rich Milton R. Dulay, Jose Jurel M. Nuevo

    Antimicrobial resistance and persistent biofilm-associated infections have renewed interest in bacteriophages as alternatives or complements to conventional antibiotics. However, broader therapeutic adoption remains constrained by slow phage discovery, incomplete genome characterization, narrow host range, complex therapeutic matching, and manufacturing variability. Artificial intelligence (AI) offers computational approaches that may help address several of these limitations. This comprehensive narrative review discusses current AI applications across the bacteriophage pipeline, including metagenomic phage discovery, genome annotation, phage–host interaction prediction, personalized phage selection, cocktail optimization, and phage–antibiotic combination design. The review also examines AI-assisted synthetic biology approaches, including receptor-binding protein redesign, CRISPR-enabled engineering, generative genome design, and biosafety screening, as well as emerging applications in bioprocess optimization, yield prediction, purification analytics, quality assurance, and supply-chain management. Current evidence suggests that AI may accelerate phage identification, improve host-range prediction, support therapeutic optimization, and strengthen manufacturing consistency, potentially facilitating the transition of phage therapy from individualized rescue interventions toward more scalable antimicrobial platforms. Nevertheless, major limitations remain, including fragmented, taxonomically biased datasets; limited external validation; restricted interpretability; privacy concerns; biosafety oversight; and evolving regulatory frameworks. Future progress will depend on standardized datasets, multimodal validation, scalable manufacturing systems, experimental and clinical verification, and coordinated regulatory development.


  • Open Access

    Recurrent Nipah virus infections: Implications for preparedness and public health response

    by Kevin Smith P. Cabuhat, Christian Joseph N. Ong, Jerico B. Ogaya, Don Eliseo Lucero-Prisno, Rich Milton R. Dulay


  • Open Access

    Submerged fermentation conditions and bioactivity profiling of mycelial extract of the Philippine Oudemansiella canarii

    by Rich Milton Dulay, Angelli Llorando, Neil Ivan San Miguel, Kenneth Rivera, Maria Ellenita Gibe De Castro, Sumaiyah Abdullah

    Philippine mushroom Oudemansiella canarii was subjected to varying liquid media, pH levels, temperatures, and agitation speeds to determine optimal conditions for mycelial biomass production. Among the tested substrates, coconut water supported the highest growth (180 mg DW/100 mL), while pH 7 and incubation at 30 °C further enhanced yields to 189 and 223.67 mg DW/100 mL, respectively. Agitation was crucial, with maximum biomass (1,847 mg DW/100 mL) achieved at 150 rpm, suggesting optimal oxygen transfer and nutrient distribution for growth. Ethanolic extract of the mycelia was subsequently evaluated for biological activities. Screening assays revealed limited antidiabetic and neuroprotective effects, with 1.42% inhibition for α-glucosidase (10 µg/mL) and −4.35% inhibition for acetylcholinesterase (10 µg/mL). In contrast, moderate antioxidant potential was observed, with 51.56% radical scavenging capacity. Cyclooxygenase inhibition assays indicated partial suppression of COX-1 (26.37%) and COX-2 (9.80%), suggesting anti-inflammatory potential. Toxicological assessments highlighted dose-dependent embryotoxicity and sublethal effects in zebrafish embryos, with high concentrations resulting in developmental delay or complete mortality (LC50 = 29.51 µg/mL). Similarly, brine shrimp lethality assays confirmed cytotoxic effects, with an LC50 value of 17.87 µg/mL. These findings suggest that while O. canarii mycelial extracts possess moderate antioxidant and low anti-inflammatory activities, they also exhibit notable toxicity at higher concentrations. Overall, the study demonstrates the potential of submerged fermentation using indigenous liquid substrates to enhance mycelial biomass production of O. canarii; however, despite the promising bioactivity results, the safety profile suggests that caution is necessary regarding its potential use in food and therapeutic development.

  • Open Access

    Oudemansiella (Physalacriaceae) mushrooms: A status review on the distribution, cultivation, composition and bioactivity profile

    by Rich Milton R. Dulay

    Oudemansiella of Physalacriaceae, Agaricomycetes, Basidiomycota is widely distributed in tropical and subtropical regions, and are known as saprophytic macrofungi. Species of this genus are edible, flavorful, nutritious, and medicinal. Hence, there is increasing attention to the value of these under-utilized myko-resources. In this context, this status review aimed to provide a species checklist of Oudemansiella and their distribution worldwide, cultivation requirements for growth and production, nutritional and bioactive compositions, and biological properties. A total of 25 species of Oudemansiella was recorded in 31 countries in Asia, North and South America, Australia, Africa, and Europe. O. canarii was found to be the most widely distributed, followed by O. platensis, O. cubensis, O. melanotricha, O. submucida, and O. australis. China had the greatest number of reported Oudemansiella species. O. canarii was the most commonly cultivated species using agro-industrial wastes such as sugarcane bagasse, eucalyptus sawdust, cotton seed hull, corncob, sawdust, and rice straw. Oudemansiella species contain carbohydrates, protein, amino acids, crude fiber, crude fat, minerals, and bioactive compounds such as oudemansin A and B, dihydroxerulin, xerulinic acid, and strobilurin C. Extracts and isolated bioactive compounds from Oudemansiella were reported to exhibit antioxidant, antifungal, antimicrobial, cytotoxic properties, and anti-trypanosomatid infection. To the best of our knowledge, this review establishes the most comprehensive checklist of Oudemansiella species. The presented data can be used as valuable information for further exploration and exploitation of the maximum profitability of Oudemansiella species. This review also provides status, challenges, and research opportunities that will ignite attention among researchers and scientists worldwide.


  • Open Access

    Optimal liquid culture conditions and bioactivity of Pycnoporus sanguineus

    by Janice S. Aguilar, Rich Milton R. Dulay, Sofronio P. Kalaw, Renato G. Reyes

    Pycnoporus sanguineus is a species of mushroom in the Philippines with promising nutritional and pharmacological potentials. In this study, the optimum nutritional and physical growth preferences of P. sanguineus in submerged conditions were established and the biological activities of ethanol extract of its mycelia were determined. The highest yield (100.13 mg/30ml) was produced in rice bran broth with a wide range of pH concentration. Biomass production was favored under 28°C, in lighted and agitated conditions with 147.20 mg/30 ml, 168.47 mg/30 ml, and 413.30 mg/30 ml, respectively. The extract inhibited the growth of Staphylococcus aureus while no antibacterial activity was observed in Escherichia coli. It was found toxic to brine shrimp with an LC50 value of 190.55 μg/ml. Exposure of zebrafish embryos to the extract caused delayed growth resulting in a lower hatching rate. Growth retardation was the most noticeable teratogenic effect of the extract after 48 hours and high mortality rates were observed in high extract concentrations. This study suggests that the optimum biomass yield of P. sanguineus can be achieved when incubated under the most favorable conditions. Mycelia of P. sanguineus could be a valuable resource of antibacterial and cytotoxic compounds.


  • Cytotoxicity of Medicinal Mushrooms Oudemansiella canarii and Ganoderma lucidum (Agaricomycetes) Against Hematologic Malignant Cells via Activation of Apoptosis-Related Markers

    by Rich Milton R. Dulay, Benigno C. Valdez, Seemanti Chakrabarti, Braham Dhillon, Esperanza C. Cabrera, Sofronio P. Kalaw, Renato G. Reyes

    Cancer is the second leading cause of death worldwide, and despite of the of the availability of the advanced chemical treatments, development of effective and safe alternatives derived from natural resources are still of high interest. Mushroom is one of the important resources of pharmacologically active cytotoxic compounds. In this paper, we report the cytotoxicity of ethanolic extracts of Oudemansiella canarii (Jungh.) Höhn. and Ganoderma lucidum (W. Curt.: Fr.) P. Karst. against nine hematologic malignant cells and describe their molecular mechanisms. Cell lines were exposed to varying concentrations of mushroom extracts for 48 h and the cell proliferation and apoptosis parameters were determined. Western blot analysis was performed to determine the extract-induced changes in the level of apoptosis-related proteins in cancer cell lines and patient-derived mononuclear cells. Results revealed that O. canarii and G. lucidum extracts exhibited cytotoxicity with IC50 values of 26.8-66.0 ppm and 48.1-78.4 ppm, respectively, in all the cancer cell lines used. Mushroom extracts inhibited cell proliferation by 57.3-72.5% (O. canarii) and 44.2-67.4% (G. lucidum), which correlates to the activation of apoptosis as indicated by increased annexin V positivity, cells in sub G0/G1 phase and production of reactive oxygen species, and decreased mitochondrial membrane potential. Western blot analysis showed increase in the level of apoptotic markers (cleaved PARP1, cleaved caspase 3 and phosphorylation of histone 2AX) and activation of the stress-activated protein kinase (SAPK/JNK) signaling pathway. The extract-activated apoptosis was also observed in mononuclear cells isolated from the peripheral blood of leukemia and lymphoma patients. In conclusion, activation of pro-apoptotic markers is one of the major mechanisms of the cytotoxicity of O. canarii and G. lucidum extracts against hematologic malignant cells.


  • Moringa oleifera leaf extract improves the mycelial biomass and antioxidant activity of mushroom Pleurotus florida (Mont.) singer

    by Benjielhyne Mimis, Aira Mariz, G Martin, Aleck Manalo, Milton Rich

    Addition of supplements in culture media enhances the production of mycelia and even the biological activities of mushroom. In the present work, the effects of Moringa oleifera leaf extract (MOLE) supplemented in coconut water as culture media on the mycelial production and antioxidant properties of Pleurotus florida were investigated. Coconut water supplemented with 9% MOLE significantly produced the maximum biomass yield of 0.35 g, followed by 6% MOLE (0.34 g). However, the highest scavenging activity against DPPH free radicals was obtained in extracts of mycelia grown in coconut water with 6% and 9% MOLE. Non-supplemented media recorded the lowest mycelial yield and scavenging activity. Increasing mycelial yield and scavenging activity was observed as the concentration of MOLE increases. This work demonstrates the utilization of M. oleifera leaves as supplement of culture media for the improved production of mycelia and enhanced antioxidant properties of P. florida.

  • Open Access

    Mycovores and entomo-associates of commercially cultivated Pleurotus florida

    by Lois Kristien F. Domingo, Mark Andrei B. Macapagal, Elaida R. Fiegalan, Rich Milton R. Dulay

    Mycovory is feeding on mycelia, fruiting bodies, or even spores of fungi particularly mushrooms. This paper reported the mycovorous insects and entomo-associates in the different developmental stages of fruiting bodies of commercially cultivated mushroom Pleurotus florida. A total of 675 specimens were collected and they were classified under 7 Orders and 15 Families. Majority of the collected insects were under Collembola (542), in which 412 of these insects belong to Poduroidea and the remaining 130 belongs to Entomobryidae. This was followed by Coleoptera (61) dominated by Staphylinidae (60), and Diptera (42) dominated by Ceratopogonidae (25) and Sciaridae (12). Collembola was found in all development stages (except Stage 2 – primordial initiation), but the highest number of this group was noted in Stage 3 – pinhead formation. However, most of the insect orders were collected in complete mycelial ramification (Stage 1), pinhead formation (Stage 3), and maturation (Stage 5) stages of the mushroom.